1. 313-336 of 365 « 1 2 ... 11 12 13 14 15 16 »
    1. News Corp. Can Keep Its 'Poison Pill' Provision, Delaware Court Rules

      News Corp. Can Keep Its 'Poison Pill' Provision, Delaware Court Rules

      NEW YORK (The Deal) -- News Corp.  may keep its poison pill in place, Delaware Chancellor Andre Bouchard ruled Tuesday. Shareholders of the media company, which publishes the Wall Street Journal and the New York Post, argued they should have a vote on the shareholder rights plan -- known as a "poison pill" -- under an agreement that News Corp.'s predecessor company -- also called News Corp ...

      Read Full Article
    2. Nelson Peltz -- Activist Investors Benefit All Shareholders

      Nelson Peltz -- Activist Investors Benefit All Shareholders

      NEW YORK (TheStreet) -- In an op-ed published this week by the Wall Street Journal, Yale School of Management's Jeffrey Sonnenfeld made some criticisms of activist investors that didn't sit well with many fund managers.  In particular, Nelson Peltz, founder and CEO of Trian Partners, is taking issue with some of Sonnenfeld's claims. Peltz argues that activist investors aren't the only winners ...

      Read Full Article
    3. At Rovi, Activist Investor's Years of Protests Against Executive Pay May Give Leverage on Board

      At Rovi, Activist Investor's Years of Protests Against Executive Pay May Give Leverage on Board

      NEW YORK (The Deal) -- Three years of protest votes by shareholders against Rovi's executive pay packages mean activist investor Glenn Welling picked a relatively soft target for his short-slate proxy fight at the digital entertainment technology provider. Welling's Engaged Capital is seeking to install three directors, including himself, on the Santa Clara, Calif.-based company's board at an ...

      Read Full Article
    4. Darden CEO Lee Moves Forward Slowly With Starboard Activist Effort

      Darden CEO Lee Moves Forward Slowly With Starboard Activist Effort

      NEW YORK (The Deal) -- Newly installed Darden Restaurants CEO Gene Lee on Friday suggested that the company is considering taking some strategic steps sought by activist investor Starboard Value soon but spinoffs sought by the insurgent fund will have to wait. Last month Darden named Lee, who had been running the company as interim CEO, as its full-time chief executive. The move comes after ...

      Read Full Article
    5. Herbalife Soars in After-Hours on FBI Probe into People Affiliated With Bill Ackman

      Herbalife Soars in After-Hours on FBI Probe into People Affiliated With Bill Ackman

      NEW YORK (TheStreet) – Shares of Herbalife soared 9% in after-hours trading on the news that people affiliated with the company's chief antagonist and activist investor Bill Ackman are being questioned as part of a federal criminal probe into potential market manipulation of Herbalife's stock. According to a report in the Wall Street Journal, the Federal Bureau of Investigation and prosecutors ...

      Read Full Article
    6. McDonald's (MCD) Stock Dropping Today After Ackman Said Investment Is 'Unlikely'

      McDonald's (MCD) Stock Dropping Today After Ackman Said Investment Is 'Unlikely'

      NEW YORK (TheStreet) -- Shares of McDonald's are dropping, down 1.24% to $91.68 in afternoon trading on Wednesday, after activist investor Bill Ackman told Bloomberg that it's "unlikely" he will invest in the fast food company. On December 17, shares of McDonald's rallied after Ackman did not deny a rumor that he had taken a stake in the company. At that time, Ackman added that the shares would ...

      Read Full Article
      Mentions: Investment
    7. Mylan Ex-CEO and Glass Lewis Debate Proxy Adviser Power

      Mylan Ex-CEO and Glass Lewis Debate Proxy Adviser Power

      A top proxy adviser and the ex-CEO of a Fortune 500 pharmaceutical company once targeted by an billionaire activist on Wednesday clashed over the role two advisory firms play in boardroom battles pitting insurgent-backed dissident directors against incumbent executives. "We should all be playing by the same rules," Robert Coury, Mylan Inc.'s executive chairman, told the U.S. Chamber of Commerce ...

      Read Full Article
    8. Activist Investor Worldview Targets Petroceltic CEO After Failed Bid

      Activist Investor Worldview Targets Petroceltic CEO After Failed Bid

      Activist investor Worldview Capital Management LLP said Thursday, Jan. 8, it will seek to oust the CEO of London-listed Petroceltic International plc citing, amongst its reasons, the aborted £606 million ($913 million) bid by Dragon Oil plc. Worldview, which owns 28% of Dublin-based Petroceltic, called for a shareholder vote to remove Brian O'Cathain, claiming he bore responsibility for "a ...

      Read Full Article
    9. Activist Investors Are Putting the Heat on Forestar Group

      Activist Investors Are Putting the Heat on Forestar Group

      The activist investors putting the heat on real estate and natural resources company Forestar Group Inc. said Tuesday they believe they are at an impasse with the company over possible changes and are considering all options to them as shareholders. The investors, SpringOwl Asset Management LLC and Cove Street Capital LLC, which own 7% of Forestar's stock, said in a telephone interview that they ...

      Read Full Article
    10. Activist-Pressured InterContinental Books Deal for Kimpton Hotels

      Activist-Pressured InterContinental Books Deal for Kimpton Hotels

      The U.K.'s InterContinental Hotels Group plc on Tuesday broke with its habit of selling real asset and returning cash to shareholders to strike a $430 million deal to buy privately held Kimpton Hotels & Restaurants and create the world's largest boutique hotels business. San Francisco-based Kimpton, like InterContinental, is an "asset-light" company, meaning it doesn't own much of its real ...

      Read Full Article
    11. Activist Investors Torn on Private Equity Partnerships

      Activist Investors Torn on Private Equity Partnerships

      Despite a proliferation in activist investing, one thing that's unlikely to repeat in 2015 is a version of Valeant Pharmaceuticals International Inc.'s $60 billion-plus hostile takeover attempt for Allergan Inc. , said Gregg Feinstein, head of M&A at Houlihan Lokey. Feinstein spoke as part of a panel discussing the investment strategy during The Deal Economy Event at the Nasdaq Exchange on ...

      Read Full Article
    12. Why the Allergan Situation Could be Unique in Dealmaking This Year

      Why the Allergan Situation Could be Unique in Dealmaking This Year

      NEW YORK (TheStreet) -- Despite the appearance this year of a team-up between an activist investor and a strategic acquirer in dealmaking, don't expect a repeat. The combination of Pershing Square Capital Management with Valeant Pharmaceuticals to pursue Allergan "may have been a one-time opportunity," said Paul Parker, co-chair of global mergers and acquisitions at Goldman Sachs , at The Deal ...

      Read Full Article
    13. Jana Partners Unveils Potential Board Slate for PetSmart

      Jana Partners Unveils Potential Board Slate for PetSmart

      Activist investor Jana Partners LLC is looking to turn up the heat on pet products retailer PetSmart Inc. , as private equity firms KKR & Co. LP and Clayton, Dubilier & Rice LLC are apparently preparing a joint offer. Jana, a hedge fund holding a 9.8% stake in the Phoenix, Ariz.-based retailer, is pressing PetSmart to sell the business. The activist has lined up nominees for PetSmart's board in ...

      Read Full Article
    313-336 of 365 « 1 2 ... 11 12 13 14 15 16 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content